Correlation Between Kamada and Nextage Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kamada and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kamada and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kamada and Nextage Therapeutics, you can compare the effects of market volatilities on Kamada and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kamada with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kamada and Nextage Therapeutics.
Diversification Opportunities for Kamada and Nextage Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kamada and Nextage is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Kamada and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Kamada is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kamada are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Kamada i.e., Kamada and Nextage Therapeutics go up and down completely randomly.
Pair Corralation between Kamada and Nextage Therapeutics
Assuming the 90 days trading horizon Kamada is expected to under-perform the Nextage Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kamada is 2.65 times less risky than Nextage Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Nextage Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 6,720 in Nextage Therapeutics on September 1, 2024 and sell it today you would earn a total of 480.00 from holding Nextage Therapeutics or generate 7.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kamada vs. Nextage Therapeutics
Performance |
Timeline |
Kamada |
Nextage Therapeutics |
Kamada and Nextage Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kamada and Nextage Therapeutics
The main advantage of trading using opposite Kamada and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kamada position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.Kamada vs. Bezeq Israeli Telecommunication | Kamada vs. Brainsway | Kamada vs. Mivne Real Estate | Kamada vs. Photomyne |
Nextage Therapeutics vs. Electreon Wireless | Nextage Therapeutics vs. Harel Insurance Investments | Nextage Therapeutics vs. Millennium Food Tech LP | Nextage Therapeutics vs. Polyram Plastic Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |